ArticleFrontiers in immunology2016

Very Late Antigen-1 Marks Functional Tumor-Resident CD8 T Cells and Correlates with Survival of Melanoma Patients.

Timothy Murray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.